Skip to main content
Terug
ARDT logo

Ardent Health Partners, LLC

Datakwaliteit: 100%
ARDT
NYSE Healthcare Medical - Care Facilities
€ 8,64
▲ € 0,17 (2,01%)
Marktkapitalisatie: 1,24B
Dagbereik
€ 8,60 € 8,83
52-Weeksbereik
€ 8,07 € 15,48
Volume
364.517
50D / 200D Gem.
€ 9,02 / € 11,35
Vorige Slotkoers
€ 8,47

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E 9,1 0,4
P/B 0,7 2,9
ROE % 9,6 3,8
Net Margin % 2,2 3,9
Rev Growth 5Y % 6,8 10,0
D/E 1,3 0,2

Belangrijkste Punten

Revenue grew 6,75% annually over 5 years — modest growth
Earnings declined -35,43% over the past year
Generating 258,61M in free cash flow
P/E of 9,11 — trading at a low valuation
Cash machine — converts 190,42% of earnings into free cash flow
Capital efficient — spends only 3,35% of revenue on capex

Groei

Revenue Growth (5Y)
6,75%
Revenue (1Y)6,01%
Earnings (1Y)-35,43%
FCF Growth (3Y)75,16%

Kwaliteit

Return on Equity
9,64%
ROIC6,18%
Net Margin2,15%
Op. Margin5,15%

Veiligheid

Debt / Equity
1,34
Current Ratio1,97
Interest Coverage5,90

Waardering

P/E Ratio
9,11
P/B Ratio0,73
EV/EBITDA8,58
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6,01% Revenue Growth (3Y) 8,13%
Earnings Growth (1Y) -35,43% Earnings Growth (3Y) 64,33%
Revenue Growth (5Y) 6,75% Earnings Growth (5Y) -3,13%
Profitability
Revenue (TTM) 6,32B Net Income (TTM) 135,81M
ROE 9,64% ROA 2,57%
Gross Margin 97,54% Operating Margin 5,15%
Net Margin 2,15% Free Cash Flow (TTM) 258,61M
ROIC 6,18% FCF Growth (3Y) 75,16%
Safety
Debt / Equity 1,34 Current Ratio 1,97
Interest Coverage 5,90 Dividend Yield 0,00%
Valuation
P/E Ratio 9,11 P/B Ratio 0,73
P/S Ratio 0,20 PEG Ratio -0,23
EV/EBITDA 8,58 Dividend Yield 0,00%
Market Cap 1,24B Enterprise Value 2,79B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6,32B 5,97B 5,41B 5,13B 4,87B
Net Income 135,81M 210,34M 50,29M 188,91M 154,26M
EPS (Diluted) 0,96 1,58 0,35 1,32 1,08
Gross Profit 6,17B 4,93B 5,27B 4,17B 3,94B
Operating Income 325,58M 405,76M 229,50M 217,03M 436,56M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2018
Total Assets 5,29B 4,96B 5,10B 4,86B 2,75B
Total Liabilities 3,61B 3,43B 4,02B 3,81B 2,03B
Shareholders' Equity 1,69B 1,13B 670,90M 639,05M 331,65M
Total Debt 2,26B 2,28B 2,40B 2,39B 1,26B
Cash & Equivalents 709,60M 556,79M 437,58M 456,12M 59,66M
Current Assets 2,06B 1,83B 1,62B 1,41B 860,42M
Current Liabilities 1,05B 945,42M 994,10M 808,60M 624,83M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#491 of 1024
46
Growth Price/Sales Ratio Focus (Ken Fisher)
#507 of 616
14

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026
Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026